
Investigator‐initiated randomized controlled trials in children with epilepsy: Mission impossible?
Author(s) -
Weijenberg Amerins,
Callenbach Petra M. C.,
Brouwer Oebele F.
Publication year - 2017
Publication title -
epilepsia open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.247
H-Index - 16
ISSN - 2470-9239
DOI - 10.1002/epi4.12024
Subject(s) - randomized controlled trial , levetiracetam , randomization , medicine , informed consent , clinical trial , family medicine , pediatrics , psychiatry , epilepsy , alternative medicine , surgery , pathology
Summary Objective In children many antiepileptic drugs ( AED s) are prescribed off‐label due to a lack of well‐designed randomized controlled trials ( RCT s). We conducted a multicenter RCT in the Netherlands to compare levetiracetam and valproic acid as monotherapy in children with newly diagnosed epilepsy. After 2 years, we had to stop this investigator‐initiated trial prematurely because the inclusion rate was too low. We analyzed the reasons for this failure, assessed the various issues involved in performing RCT s in children, and now give recommendations for future studies. Methods A questionnaire was completed by all investigators involved in the study. It included questions about the motivation to participate and the perceived reasons for recruitment failure. We also studied literature about financial, logistic, legal, and ethical aspects of RCT s in children. Results Main reasons for recruitment failure were overestimation of the number of eligible AED ‐naive children referred by general pediatricians; personal preferences of investigators for specific antiepileptic drugs; and the extensive administrative load due to extra regulations and guidelines for children. Fundraising for investigator‐initiated trials is difficult and the majority of RCT s concerning AED s are sponsored by pharmaceutical companies. Involving children requires balancing between protection and participation; the randomization procedure and obtaining informed consent are complex for both children and parents. Significance Performing RCT s with AED s in children is important but complicated by logistic, regulatory, legal, and ethical restrictions. Based on our recent experience, our advice to colleagues who are planning a similar trial would be to perform a feasibility pilot study; to set up intensive collaboration with referring pediatricians; to arrange support of a clinical trials unit and a local research nurse during the complete trial period; and to incorporate the possibility of extending the recruitment period. Major investments, both financially from governmental organizations and in time, are imperative for independent RCT s in children.